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Abstract: 
Prior to any large-scale basic science or clinical research project being funded, it is 
important for researchers to gather preliminary data. This is essential for providing 
evidence for the feasibility of research projects and helping to design larger scale 
studies. When gathering preliminary data one needs to consider how much data are 
required, how this work is to be funded and where and when the data will be 
generated. Most importantly researchers should ensure that the planned data 
collection will be meaningful, serve its intended purpose and follow the principles of 
good clinical practice.  
 
What are preliminary data? 
Preliminary data are the data generated from small-scale research projects to evaluate 
feasibility, prior to conducting full research studies.  Preliminary data are used to test 
approaches using small sample sizes, provide proof of concept or evidence to support 
a working hypothesis or they are used as pilot data for grant funding applications. As 
such they are useful for showing the progression of an idea and likely success of future 
research projects. In addition preliminary data may also be used to demonstrate the 
significance or potential impact of a research project. In some cases, preliminary data 
can also be combined with data from the full research project to generate a larger data 
set.  
 
Why do you need to gather preliminary data? 
Preliminary data are useful when designing a research project as they can confirm that 
a planned approach is likely to succeed and has the potential to answer the questions 
of the research project. These data do not usually provide conclusive proof as they are 
limited by the size and nature of these small-scale or pilot studies. They are useful for 
highlighting flaws in design, sample collection, data generation or analysis. 
Consequently they enable troubleshooting and the design of full research studies to be 
improved.  
  
In clinical trial research there are a number of reasons why one might want to gather 
preliminary data, usually via a feasibility or pilot study. Clinical trials are generally very 
expensive, resource intensive and time-consuming. Going straight into a large fully 
powered clinical trial may be wasteful if for example patients would unlikely to be 
willing to take part in the study, if there are not enough eligible patients available to be 
recruited in a timely manner or if it is more difficult to deliver the clinical trial 
interventions than originally anticipated.  
 To address these issues, preliminary data may be gathered on the acceptability of the 
trial interventions to patients, the number of eligible patients the proposed trial unit 
sees per month and the practicalities of the clinicians performing the trial 
interventions at the trial unit. The preliminary data may confirm that patients are 
willing to accept the trial interventions, that there needs to be more than the originally 
anticipated number of centres to complete recruitment in a timely manner and that 
adjustments for instance in theatre availability are required to be able to practically 
deliver the interventions planned. A more expansive list of reasons for gathering 
preliminary data in clinical trial research is given in Table 1: 
 
  
Examples of reasons for gathering preliminary data for clinical trial research 
Plan sample size calculation of the main study – e.g. estimate standard deviation of 
the primary outcome measure 
 
Assess the willingness of clinicians to participate in the trial 
 
Assess the willingness of participants to be randomised in a trial 
 
Assess the number of eligible patients for the trial 
 
Assess recruitment rate 
 
Assess adherence to trial protocol 
 
Assess whether the randomization process works well 
 
Assess whether the trial interventions can be practically delivered 
 
Table 1: Reasons for gathering preliminary data in clinical trial research, adapted 
from the National Institute for Health UK1  
 
Preliminary data are usually gathered prior to obtaining funding for a full research 
project. They are an essential and usually mandatory part of a funding application, 
providing supporting data and context for the proposed research.  
In basic science research, gathering preliminary data may involve generating 
laboratory reagents and resources or collecting clinical samples and so can indicate the 
feasibility of the research approach and the team’s ability to deliver. Preliminary data 
can demonstrate the suitability and applicability of novel methodologies and 
technologies, particularly if these are challenging or risky. They can also demonstrate 
technical ability and competence of the research team.  
 
In some cases it may also be possible to publish preliminary data in small research 
articles or present the data at research conferences. As it is usually part of a smaller 
project, this is usually a more accessible route for those interested in experiencing 
research than a larger scale study. This can help one determine whether this is 
something they enjoy and want to commit to spending more time on. 
 
How much preliminary data should you gather? 
Preliminary data are gathered from small-scale initial experiments designed to provide 
critical pieces of evidence that will support a research idea. They do not need to be a 
complete piece of research but the data should be meaningful. For example basic 
science preliminary data do not necessarily need to reach statistical significance but 
they should not be underpowered so as to produce useless results that cannot inform 
on the full research study. It is important to consider how small a sample one needs to 
generate preliminary data and how many replicates are required. Inadequate 
preliminary data are often the result of over-interpretation and insufficient sample 
sizes.  
 
For clinical trial research, although it can be challenging to decide how many patients a 
feasibility or pilot study should have, a sample size should be set a priori, with clear 
reasoning for the size chosen relating to the outcomes that the researcher wants to 
obtain. This is a complex topic and a good starting point for sample size calculation for 
clinical trial pilot studies can be found in work by Thabane et al.,2. A realistic and 
achievable piece of research should be planned that generates preliminary data in a 
reasonable time frame and addresses the purpose for which it was intended. 
 
It is also important not to generate so much preliminary data for a grant application 
that it looks like you have already done the majority of the work and answered your 
research questions. 
 
Demonstrating how power calculations in the main study can be influenced by 
preliminary data 
In a full study, power calculations are necessary to decide how many data points one 
needs to collect or how many participants one needs to recruit to be able to observe a 
statistically significant difference between two groups. Very simply they are based on 
knowing firstly the level of significance needed (usually p=0.05 for scientific research in 
medicine), the approximate effect change between groups i.e if two treatments are 
being compared: A vs B and A has a predicted 10% efficacy compared to B which has a 
predicted 50% efficacy then the difference is 40% or 0.40. This information on 
predicted efficacy is what is usually obtained from preliminary data gathering or prior 
studies. Finally, knowing how much one wants their study to be powered (80% power 
is commonly used) allows one to input these parameters into a formula to work out 
how many data points or participants are needed to appropriately power the main 
study.  
 
As can be expected if two conditions show a very small effect change between them 
then the number of patients or samples required to adequately power a study needs 
to be far greater in order to detect a significant difference. Further to this the more 
accurately one can estimate the treatment effect from preliminary data or other 
studies the more accurate the power calculation will be. This highlights the importance 
of conducting an adequate literature review, as discussed in another article from this 
series of publications3. Further information and online power calculators can be found 
at ClinCalc.com4.  
 
Knowledge of the estimated sample size helps researchers to plan their future study 
and decide whether it is feasible to run at all. For instance a longer timeline may be 
planned if it is realised that a power calculation estimates over 1000 patients are 
required, compared to initial thoughts of 100 patients. This is why most funding bodies 
will ask for a power calculation when considering whether to fund a particular study. 
Extremely large clinical studies without a large enough clinical network to run the 
study in may be deemed as non-feasible by trial funders. Questions will be raised 
about the importance of such a large study if the estimated treatment differences are 
small. 
 
How to fund gathering preliminary data? 
There are a variety of informal and formal mechanisms to fund the collection of 
preliminary data. These include using existing grant funding to generate preliminary 
data for a new research project, where an idea or hypothesis stems from data 
generated during the funded research project. In addition there are funding 
opportunities designed explicitly for gathering preliminary data. In the UK these 
include seed corn funding, pump-priming funding, pilot and small research grants, as 
well as pre- and post-doctoral research bursaries for clinical trainees and starter grants 
for clinical lecturers (Table 2). 
 
Funding Type Funder Purpose 
Seed corn  Rosetrees Trust5 
 
Royal Society6 
Obtaining data for applications to major 
funders 
Purchasing specialised equipment and 
consumables (early career researchers) 
Pump-priming Royal College of 
Surgeons7 
 
Assisting newly appointed consultants 
and senior lecturers in their independent 
research careers 
Royal College of 
Surgeons of 
Edinburgh8 
 
Funding small research projects within 
the College’s priority area (surgical 
trainees and recently appointed 
consultants) 
Small research 
grants 
Bowel and Cancer 
Research9 
 
 
Carnegie Trust10 
 
 
Chief Scientist Office11 
 
 
 
Tenovus Scotland12 
 
 
Funding proof-of-principle studies to 
collect data for applications to major 
funders 
 
Funding stand alone or initial studies that 
lead to more extensive work 
 
Funding for short projects to provide key 
supporting evidence to underpin 
applications to major funders 
 
Funding for innovative, patient-related 
projects and particularly to preliminary 
“pump priming” studies leading to 
  
The Urology 
Foundation13 
applications to major funders 
 
Funding for projects that seek to improve 
services and treatments and 
communications with patients and carers 
Research 
bursaries 
Cancer Research UK14 
 
 
Cancer Research UK15 
Short-term funding to get involved in 
research projects (early career) 
 
Funding for research costs for a small 
research project (post PhD clinical 
trainees) 
Starter grants Academy of Medical 
Sciences16 
Supporting clinical lecturers to develop 
and strengthen their research careers 
Table 2:  Examples of funders who provide small research grants 
 
How to get involved in gathering preliminary data? 
The key to gathering preliminary data is to have a clear idea of the overarching 
research question and how the preliminary data fits into the package of research 
planned to answer the research question. A good way to get involved is to contact an 
established University-affiliated research unit, which will help with the research 
question and research package and may have opportunities to get involved in the 
gathering of preliminary data. They will also have familiarity with the funding streams 
available for funding preliminary data collection and main studies. Opportunities for 
medical professionals can be taken alongside clinical training (e.g. Academic Clinical 
Fellow / Clinical Lecturer / in one’s free time), out of programme in a dedicated 
research period (e.g. MD/PhD/MSc) or as a medical student (e.g. BSc) (see the article 
on non-clinical laboratory based research17 that is part of this series of publications). 
These opportunities are often competitive and it is important to contact the research 
unit that one is interested in to meet with them and signal interest.  
 
Research governance and good clinical practice (GCP)  
When working with any clinical data adherence to local Research and Development 
(R&D) policies and an understanding of Good Clinical Practice (GCP) are essential in 
order to protect patients’ welfare and confidentiality and to ensure any data can be 
considered part of future publications. These steps can sometimes be seen as barriers 
but local R&D teams provide far more support than just registration and ethical 
approval, with advice on data analysis and potential collaborations (see the article on 
getting to grips with clinical research18 and setting up clinical research studies in the 
NHS in England19 that are part of this series of publications). GCP training can be 
accessed either locally by attending courses (through your local R&D department) or 
via online e-learning provided by the National Institute of Health Research (NIHR)20.  
 
Using existing databases as an alternative source of preliminary data 
Carrying out new experiments or clinical studies is a common way to obtain 
preliminary data. However there are alternative sources of data that can be used, such 
as mining data from existing databases. Clinicians are constantly exposed to patient 
data that could be used as preliminary data. A hospital is essentially an amalgam of 
biochemical, pathological, microbiological and medical physics imaging laboratories. By 
working with audit departments, biobanks, data repositories and other departments 
such as radiology and microbiology and pathology it is possible to access many forms 
of retrospective clinical data which can be analysed to help generate some preliminary 
data for a research proposal.  
 
Take a laparoscopic nephrectomy, a common urological procedure, as an example. Just 
a single elective procedure produces a large amount of data, which may be gathered 
to answer a clinical question. Data available pre-operatively include biopsy 
histopathology, staging scans, blood tests and patient parameters such as blood 
pressure and body mass index measured in pre-assessment clinic. Intra-operatively, 
parameters such as procedure time and blood loss are available. Post-operatively data 
on tumour grading, staging, follow-up scans and survival data are available. These data 
can be analysed to look for associations between variables and outcomes, which may 
help provide preliminary data for a research proposal in the field of nephrectomy. 
 
With over 900 nephrectomies reported in the 2009 BAUS audit21,  it can be clearly seen 
that the volume of data produced by routine procedures alone is huge. The collection 
of preliminary data may be aided by these large public datasets, which have far greater 
statistical power than smaller cohorts.   
 
 
Take home messages: 
 
 Preliminary data are generated from small-scale research projects 
 
 Gathering preliminary data is useful for testing the likely success of a future 
research project 
 
 Preliminary data are necessary for applying for research funding 
 
 Existing clinical databases can be an alternative source of preliminary data 
 
 Preliminary data should be meaningful and offer insight to the main study 
 
 Research governance and ethical approval are essential for gathering 
preliminary data 
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